# Hypercalciuria in Sanjad-Sakati Syndrome: A Retrospective Evaluation of Kidney Involvement Indicators

**Authors:** Vina Tresa, Saima Zeb Shaikh, Saima Mehmood, Anwar AL-Omairi, Komal Fatima, Dana Ahmed Al Nabhani, Saif Al Yaarubi

PMC · DOI: 10.7759/cureus.102457 · Cureus · 2026-01-28

## TL;DR

This study found that all children with Sanjad-Sakati syndrome had high urine calcium levels, with many showing kidney damage, highlighting the need for regular kidney monitoring.

## Contribution

The study is the first to comprehensively report kidney involvement in Sanjad-Sakati syndrome through a large pediatric cohort.

## Key findings

- All 15 patients with Sanjad-Sakati syndrome exhibited hypercalciuria.
- 66.7% of patients had nephrocalcinosis, and 13.3% had nonobstructive kidney stones.
- 60% of patients had normal kidney function at last follow-up, while others showed early chronic kidney disease.

## Abstract

Objective: This study aimed to evaluate the kidney and urinary abnormalities in children diagnosed with Sanjad-Sakati syndrome (SSS).

Methods: This was a retrospective, descriptive hospital-based study performed at the Child Health Department, Sultan Qaboos University Hospital, Oman. The study included all pediatric patients up to the age of 15 years who presented with clinically and/or genetically confirmed SSS from January 2006 to December 2020.

Results: Fifteen patients were enrolled in the study. Hypercalciuria was present in 15 (100%) patients. The majority of children were observed to be less than five years at the time of onset of hypercalciuria (age range from 2 to 14 years). Nephrocalcinosis was observed in 10 (66.7%) patients. Nonobstructive kidney stones were identified in two (13.3%) patients at ages 6 and 11 years. At the last follow-up, nine (60%) had normal kidney function, while four (26.7%) and two (13.3%) patients were observed to have chronic kidney disease stages 1 and 2, respectively. No case of end-stage kidney disease was detected.

Conclusion: These results highlight significant kidney involvement, particularly hypercalciuria and nephrocalcinosis, in patients with SSS, followed by consequent stones and progressive kidney dysfunction, indicating the need for regular kidney surveillance to ensure timely detection and management of evolving kidney disease.

## Linked entities

- **Diseases:** Sanjad-Sakati syndrome (MONDO:0009426), chronic kidney disease (MONDO:0005300), end-stage kidney disease (MONDO:0004375)
- **Species:** Homo sapiens (taxon 9606)

## Full-text entities

- **Genes:** SLC34A1 (solute carrier family 34 member 1) [NCBI Gene 6569] {aka FRTS2, HCINF2, NAPI-3, NPHLOP1, NPT2, NPTIIa}, TBCE (tubulin folding cofactor E) [NCBI Gene 6905] {aka HRD, KCS, KCS1, PEAMO, pac2}, TBX1 (T-box transcription factor 1) [NCBI Gene 6899] {aka CAFS, CATCH22, CTHM, DGCR, DGS, DORV}, NEBL (nebulette) [NCBI Gene 10529] {aka C10orf113, LASP2, LNEBL, bA165O3.1}, GATA3 (GATA binding protein 3) [NCBI Gene 2625] {aka HDR, HDRS}, FAM111A (FAM111 trypsin like peptidase A) [NCBI Gene 63901] {aka GCLEB, KCS2}, SOX3 (SRY-box transcription factor 3) [NCBI Gene 6658] {aka GHDX, MRGH, PHP, PHPX, SOXB}, PTH (parathyroid hormone) [NCBI Gene 5741] {aka FIH1, PTH1}
- **Diseases:** Mortality (MESH:D003643), intellectual disability (MESH:D008607), hypoparathyroidism-deafness-renal dysplasia syndrome (MESH:C537907), muscle spasms (MESH:D013035), Kidney stones (MESH:D007669), infections (MESH:D007239), DiGeorge syndrome (MESH:D004062), end-stage kidney disease (MESH:D007676), Hypercalciuria (MESH:D053565), calcium loss (MESH:D002128), Kidney Involvement (MESH:D007674), tetany (MESH:D013746), tubulointerstitial damage (OMIM:162000), developmental delay (MESH:D002658), hypocalcemic seizures (MESH:D053098), PTH deficiency (MESH:D010279), Kenny-Caffey Syndrome type 1 (MESH:C537021), X-linked hypoparathyroidism (MESH:C562782), growth retardation (MESH:D006130), tubular dysfunction (MESH:D005198), nephrolithiasis (MESH:D053040), CKD (MESH:D051436), growth failure (MESH:D051437), craniofacial dysmorphisms (MESH:C537512), Nephrocalcinosis (MESH:D009397), Kenny-Caffey syndrome type 2 (MESH:C537020), seizures (MESH:D012640), autosomal recessive disorder (MESH:D030342), SSS (MESH:C537157), obstructive uropathy (MESH:C536483), Hypoparathyroidism (MESH:D007011)
- **Chemicals:** MREC#2607 (-), creatinine (MESH:D003404), Calcium (MESH:D002118), 1,25(OH)2 D (MESH:C097949), 1,25-dihydroxyvitamin D3 (MESH:D002117), phosphate (MESH:D010710), vitamin D (MESH:D014807)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12947032/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12947032/full.md

## References

22 references — full list in the complete paper: https://tomesphere.com/paper/PMC12947032/full.md

---
Source: https://tomesphere.com/paper/PMC12947032